Literature DB >> 6160722

Intestinal metaplasia with colonic-type sulphomucins in the gastric mucosa; its association with gastric carcinoma.

P Sipponen, K Seppälä, K Varis, L Hjelt, T Ihamäki, M Kekki, M Siurala.   

Abstract

The occurrence of intestinal metaplasia with colonic-type sulphomucins: (abbreviated: s-IM or s-positive IM) in the gastric mucosa was studied in 125 patients with gastric carcinoma (GCA), 62 patients with pernicious anemia (PA), 301 and 183 first-degree relatives of GCA and PA patients, 406 outpatients and in 358 controls matched from a large population sample. The sulphomucins (s-mucins) were demonstrated histochemically in endoscopic biopsy specimens by using high iron diamine and Alcian blue (pH 1) methods. The prevalence of s-IM, especially the strongly s-positive IM, was significantly higher in GCA patients than in other series or controls of the same age group. Further, s-IM was significantly more common in PA patients and its prevalence higher in GCA relatives and outpatients than in other series or controls. The occurrence of s-IM was also age-dependent and dependent on the extent of IM. It was suggested that the occurrence of s-IM can be used as a sign of lesions that are more closely associated with GCA than IM is in general.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6160722     DOI: 10.1111/j.1699-0463.1980.tb02489.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand A        ISSN: 0365-4184


  29 in total

1.  Correlation between epithelial cell proliferation and histological grading in gastric mucosa.

Authors:  D A Lynch; N P Mapstone; A M Clarke; P Jackson; P Moayyedi; M F Dixon; P Quirke; A T Axon
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

2.  Biomarkers in various types of atrophic gastritis and their diagnostic usefulness.

Authors:  Kazimierz Rembiasz; Peter C Konturek; Danuta Karcz; Stanislaw J Konturek; Władysław Ochmanski; Wladyslaw Bielanski; Andrzej Budzynski; Jerzy Stachura
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

3.  Is intestinal metaplasia a risk for gastric carcinoma?

Authors:  P Sossai; R Cielo; R Barbazza
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

Review 4.  Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence.

Authors:  Carlos A González; José M Sanz-Anquela; Javier P Gisbert; Pelayo Correa
Journal:  Int J Cancer       Date:  2013-02-05       Impact factor: 7.396

5.  Intestinal metaplasia in endoscopic biopsy specimens of gastric mucosa.

Authors:  G A Rothery; D W Day
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

6.  Increased expression of cyclooxygenase-2 in first-degree relatives of gastric cancer patients.

Authors:  Jin-Ting Zhang; Ming-Wei Wang; Zhen-Long Zhu; Xiao-Hui Huo; Jian-Kun Chu; Dong-Sheng Cui; Liang Qiao; Jun Yu
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

7.  DNA flow cytometric measurements in inflammatory and malignant human gastric lesions.

Authors:  E Deinlein; H Schmidt; J F Riemann; R Grässel-Pietrusky; O P Hornstein
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

8.  Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma.

Authors:  Yao Zheng; Lin Wang; Jian-Ping Zhang; Jing-Yan Yang; Zhu-Mei Zhao; Xiao-Ying Zhang
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

9.  Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up.

Authors:  T Rokkas; M I Filipe; G E Sladen
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

10.  Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres.

Authors:  M I Filipe; F Potet; W V Bogomoletz; P A Dawson; B Fabiani; P Chauveinc; A Fenzy; B Gazzard; D Goldfain; R Zeegen
Journal:  Gut       Date:  1985-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.